Sernova Biotherapeutics Inc (TSX:SVA)
0.1650
+0.0050 (3.13%)
Jan 22, 2026, 3:40 PM EST
Sernova Biotherapeutics Employees
Sernova Biotherapeutics had 8 employees as of October 31, 2025. The number of employees decreased by 9 or -52.94% compared to the previous year.
Employees
8
Change
-9
Growth
-52.94%
Revenue / Employee
n/a
Profits / Employee
-1.97M CAD
Market Cap
53.87M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Oct 31, 2025 | 8 | -9 | -52.94% |
| Jul 31, 2025 | 13 | -4 | -23.53% |
| Apr 30, 2025 | 16 | - | - |
| Oct 31, 2024 | 17 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,000 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| Trulieve Cannabis | 6,000 |
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| WELL Health Technologies | 1,507 |
| Vireo Growth | 520 |
Sernova Biotherapeutics News
- 4 months ago - Sernova converts $13.3M debt to equity ahead of clinical milestone - Seeking Alpha
- 4 months ago - Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang - Newsfile Corp
- 4 months ago - Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors - TheNewswire
- 4 months ago - Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference - TheNewswire
- 7 months ago - Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes - GlobeNewsWire
- 8 months ago - Sernova Appoints Jonathan Rigby as Interim Chair - GlobeNewsWire
- 8 months ago - Chair of Sernova Biotherapeutics Resigns - GlobeNewsWire
- 8 months ago - Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes - GlobeNewsWire